KR20190026001A - 테트라하이드로나프티리딘펜탄아미드 인테그린 길항물질 - Google Patents

테트라하이드로나프티리딘펜탄아미드 인테그린 길항물질 Download PDF

Info

Publication number
KR20190026001A
KR20190026001A KR1020197003579A KR20197003579A KR20190026001A KR 20190026001 A KR20190026001 A KR 20190026001A KR 1020197003579 A KR1020197003579 A KR 1020197003579A KR 20197003579 A KR20197003579 A KR 20197003579A KR 20190026001 A KR20190026001 A KR 20190026001A
Authority
KR
South Korea
Prior art keywords
hydrocarbyl
patient
alkyl
tetrahydro
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020197003579A
Other languages
English (en)
Korean (ko)
Inventor
배리 에스. 콜러
마르타 필리졸라
마이클 앤드류 폴리
Original Assignee
더 락커펠러 유니버시티
이칸 스쿨 오브 메디슨 엣 마운트 시나이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 락커펠러 유니버시티, 이칸 스쿨 오브 메디슨 엣 마운트 시나이 filed Critical 더 락커펠러 유니버시티
Publication of KR20190026001A publication Critical patent/KR20190026001A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1020197003579A 2016-07-05 2017-07-05 테트라하이드로나프티리딘펜탄아미드 인테그린 길항물질 Ceased KR20190026001A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662358330P 2016-07-05 2016-07-05
US62/358,330 2016-07-05
US201662374234P 2016-08-12 2016-08-12
US62/374,234 2016-08-12
PCT/US2017/040657 WO2018009501A1 (en) 2016-07-05 2017-07-05 Tetrahydronaphthyridinepentanamide integrin antagonists

Publications (1)

Publication Number Publication Date
KR20190026001A true KR20190026001A (ko) 2019-03-12

Family

ID=60912284

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197003579A Ceased KR20190026001A (ko) 2016-07-05 2017-07-05 테트라하이드로나프티리딘펜탄아미드 인테그린 길항물질

Country Status (9)

Country Link
US (1) US11192889B2 (https=)
EP (1) EP3481814B1 (https=)
JP (1) JP2019524702A (https=)
KR (1) KR20190026001A (https=)
CN (1) CN109476632A (https=)
AU (1) AU2017292754B2 (https=)
CA (1) CA3029829A1 (https=)
MX (1) MX2019000043A (https=)
WO (1) WO2018009501A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3509590A4 (en) 2016-09-07 2020-12-02 Pliant Therapeutics, Inc. N-ACYL AMINO ACID COMPOUNDS AND METHODS OF USE
MX394210B (es) 2017-02-28 2025-03-04 Morphic Therapeutic Inc INHIBIDORES DE INTEGRINA AVß6.
MA52117A (fr) 2017-02-28 2022-04-06 Morphic Therapeutic Inc Inhibiteurs de l'intégrine (alpha-v) (bêta-6)
FI3761980T3 (fi) * 2018-03-07 2024-02-21 Pliant Therapeutics Inc Aminohappoyhdisteitä ja käyttömenetelmiä
TWI841573B (zh) 2018-06-27 2024-05-11 美商普萊恩醫療公司 具有未分支連接子之胺基酸化合物及使用方法
AU2019318538B2 (en) 2018-08-08 2025-02-06 The General Hospital Corporation Polypeptide integrin antagonists
WO2020047208A1 (en) 2018-08-29 2020-03-05 Morphic Therapeutic, Inc. Inhibitors of (alpha-v)(beta-6) integrin
WO2020047239A1 (en) 2018-08-29 2020-03-05 Morphic Therapeutic, Inc. INHIBITING αV β6 INTEGRIN
SI3844162T1 (sl) 2018-08-29 2025-06-30 Morphic Therapeutic, Inc. Zaviralci integrina alfa v beta6
TW202028179A (zh) 2018-10-08 2020-08-01 美商普萊恩醫療公司 胺基酸化合物及使用方法
CN114173803A (zh) * 2019-04-08 2022-03-11 普利安特治疗公司 氨基酸化合物的剂型和方案
TW202329973A (zh) * 2021-10-14 2023-08-01 美商普萊恩醫療公司 整合素抑制劑及其與其他藥劑併用之用途
WO2024125634A1 (zh) * 2022-12-16 2024-06-20 西藏海思科制药有限公司 一种四氢萘啶类化合物及其在医药上的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048861A (en) * 1997-12-17 2000-04-11 Merck & Co., Inc. Integrin receptor antagonists
KR20010033248A (ko) * 1997-12-17 2001-04-25 폴락 돈나 엘. 인테그린 수용체 길항제
CN1589145A (zh) * 1999-06-02 2005-03-02 麦克公司 αv整联蛋白受体拮抗剂
FR2808798A1 (fr) 2000-05-09 2001-11-16 Hoechst Marion Roussel Inc Nouveaux derives antagonistes du recepteur de la vitronectine
AU7793501A (en) * 2000-07-26 2002-02-05 Merck & Co Inc Alpha v integrin receptor antagonists
EP1389205B1 (en) * 2001-04-09 2005-12-21 Ortho-McNeil Pharmaceutical Research Inc. Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
JP2003277340A (ja) * 2002-03-22 2003-10-02 Toray Ind Inc 接着分子阻害剤及び新規アミノ酸誘導体
EP2456460A4 (en) 2009-07-24 2013-02-20 Univ California METHOD AND COMPOSITIONS FOR TREATING AND PREVENTING DISEASES ASSOCIATED WITH AVB5 INTEGRIN
PT2953948T (pt) * 2013-02-07 2017-12-12 Scifluor Life Sciences Inc Antagonistas de integrina fluorada
US8901144B2 (en) 2013-02-07 2014-12-02 Scifluor Life Sciences, Llc Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives

Also Published As

Publication number Publication date
EP3481814A4 (en) 2019-12-04
EP3481814A1 (en) 2019-05-15
WO2018009501A1 (en) 2018-01-11
EP3481814B1 (en) 2022-04-27
CA3029829A1 (en) 2018-01-11
JP2019524702A (ja) 2019-09-05
AU2017292754A1 (en) 2019-01-24
AU2017292754B2 (en) 2021-06-17
US11192889B2 (en) 2021-12-07
CN109476632A (zh) 2019-03-15
MX2019000043A (es) 2019-07-04
US20200181138A1 (en) 2020-06-11

Similar Documents

Publication Publication Date Title
KR20190026001A (ko) 테트라하이드로나프티리딘펜탄아미드 인테그린 길항물질
AU2013265256B2 (en) Substituted pyrrolidines as factor XIa inhibitors for the treatment of thromboembolic diseases
TWI631099B (zh) 作為甲醯基肽受體樣－１（ｆｐｒｌ－１）受體調節劑的ｎ－脲取代之胺基酸之醯胺衍生物
US7550481B2 (en) Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of Alzheimer's disease
CN101622243B (zh) 磺酰胺衍生物
KR101088942B1 (ko) Ｅｐ2 작용제
US8580817B2 (en) 1-(1-OXO-1,2,3,4-tetrahydroisoquinolin-7-YL)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
KR101743280B1 (ko) Ccr2의 사이클로헥실-아제티디닐 길항제
JP5969016B2 (ja) Ｔｒｐｖ４拮抗薬
US20150232464A1 (en) Imidazopyridine compounds
JP2020515583A (ja) アリールシクロプロピル−アミノ−イソキノリニルアミド化合物
KR20140040774A (ko) 이미다조피리딘 화합물
JP2018511616A (ja) 短鎖デヒドロゲナーゼ活性を調節する組成物および方法
TWI598348B (zh) 雜環化合物及其用途
KR20140145203A (ko) 포르밀 펩타이드 수용체 2 조절물질로서 (2-우레이도아세트아미도)알킬 유도체
KR20010024141A (ko) 비트로넥틴 수용체 길항 물질
JP7301758B2 (ja) 縮合二環式化合物、その組成物及び応用
JP2025517513A (ja) Ｔｒｐｍ３媒介性障害を治療するための新たな誘導体
TW202235078A (zh) 自分泌運動因子（ａｕｔｏｔａｘｉｎ）之新穎的抑制劑
WO2025074305A1 (en) N-(1-(aminomethyl)cyclopropyl)(aryl or heteroaryl) carboxamide derivatives

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20190201

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20200630

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20220222

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20220829

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20220222

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I